Chymotrypsin and Astigmatism - from FDA reports


Summary

There is no Astigmatism reported by people who take Chymotrypsin yet. This review analyzes which people have Astigmatism with Chymotrypsin. It is created by eHealthMe based on reports from FDA, and is updated regularly.

What to expect?

If you take Chymotrypsin and have Astigmatism, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Chymotrypsin and have Astigmatism

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Dec, 17, 2017

No report is found.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Astigmatism when taking Chymotrypsin?

Expand the study to include all drugs with the same ingredients

Astigmatism and drugs with ingredients of chymotrypsin.

Expand the study to include reports from both FDA and eHealthMe

Astigmatism and Chymotrypsin from FDA and eHealthMe reports

Chymotrypsin

Chymotrypsin has active ingredients of chymotrypsin. (latest outcomes from Chymotrypsin 32 users)

Astigmatism

Astigmatism (refractive error of the eye in which parallel rays of light from an external source do not converge on a single focal point on the retina) has been reported by people with osteoporosis, multiple myeloma, pain, multiple sclerosis, depression (latest reports from 1,007 Astigmatism patients).

Browse all side effects of Chymotrypsin

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Astigmatism

Astigmatism

Could your condition cause Astigmatism

Astigmatism

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Chymotrypsin and have Astigmatism.